7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atrial Remodeling D064752 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angina, Stable D060050 2 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peri-Implantitis D057873 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Osteophyte D054850 2 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypercalciuria D053565 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fractures, Bone D050723 4 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Hashimoto Disease D050031 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Malnutrition D044342 6 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Hearing Loss D034381 3 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Brain Infarction D020520 17 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lithiasis D020347 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hot Flashes D019584 5 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Sepsis D018805 11 associated lipids
Arthralgia D018771 8 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Foot Injuries D018409 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetic Foot D017719 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Microvascular Angina D017566 2 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Myocardial Ischemia D017202 11 associated lipids
beta-Thalassemia D017086 5 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carotid Stenosis D016893 15 associated lipids
POEMS Syndrome D016878 1 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bacteremia D016470 9 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Fractures, Stress D015775 2 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
HIV Infections D015658 20 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hyperostosis D015576 1 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Jurado S et al. Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. 2010 Osteoporos Int pmid:19436932
Ulivieri FM et al. Increased osteoprotegerin in Italian haemodialysis patients. 2006 Osteoporos Int pmid:17019516
Jiang SD et al. Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats. 2007 Osteoporos Int pmid:17036173
Findlay DM and Atkins GJ Relationship between serum RANKL and RANKL in bone. 2011 Osteoporos Int pmid:21850548
Atkins GJ et al. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. 2009 Osteoporos Int pmid:18763010
Zhao HY et al. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. 2008 Osteoporos Int pmid:17703270
Dovio A et al. Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis. 2008 Osteoporos Int pmid:17703272
Campbell GM et al. Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. 2011 Osteoporos Int pmid:20480144
Wheater G et al. Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. 2011 Osteoporos Int pmid:21625887
Niu YB et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. 2012 Osteoporos Int pmid:22535190
Ominsky MS et al. The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys. 2007 Osteoporos Int pmid:17384898
Mezquita-Raya P et al. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. 2005 Osteoporos Int pmid:15711777
Belaya ZE et al. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. 2013 Osteoporos Int pmid:23358608
Rutges JP et al. Hypertrophic differentiation and calcification during intervertebral disc degeneration. 2010 Osteoarthr. Cartil. pmid:20723612
Sanchez C et al. Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. 2009 Osteoarthr. Cartil. pmid:18974013
Bellido M et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. 2011 Osteoarthr. Cartil. pmid:21820069
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Pantsulaia I et al. Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. 2010 Osteoarthr. Cartil. pmid:20633673
Liu YD et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. 2014 Osteoarthr. Cartil. pmid:24316289
Pecchi E et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. 2012 Osteoarthr. Cartil. pmid:22179028
El Hadj Othmane T et al. [Osteoprotegerin: regulator, protector and marker]. 2008 Orv Hetil pmid:18842549
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Kawasaki K et al. Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement. 2006 Orthod Craniofac Res pmid:16918678
Fujita S et al. Low-energy laser stimulates tooth movement velocity via expression of RANK and RANKL. 2008 Orthod Craniofac Res pmid:18713151
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Nishijima Y et al. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. 2006 Orthod Craniofac Res pmid:16764680
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Tan YY et al. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. 2010 Orthod Craniofac Res pmid:21040465
George A and Evans CA Detection of root resorption using dentin and bone markers. 2009 Orthod Craniofac Res pmid:19627525
Hartsfield JK Pathways in external apical root resorption associated with orthodontia. 2009 Orthod Craniofac Res pmid:19627526
Yamaguchi M RANK/RANKL/OPG during orthodontic tooth movement. 2009 Orthod Craniofac Res pmid:19419454
Lee AZ et al. Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18585627
da Silva TA et al. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18061491
Andrade FR et al. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18928898
Menezes R et al. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. 2006 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:16920551
He J et al. Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. 2004 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:14970783
de Lange J et al. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17703964
Kawashima N et al. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17336108
Giorgetti AP et al. Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20573527
Kaneyama K et al. Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. 2003 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:12973279
Pérez-Sayáns M et al. RANK/RANKL/OPG role in distraction osteogenesis. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20163972
Elias LS et al. Markers of bone remodeling in neoplastic and bone-related lesions. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20955951
Qu Z et al. Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. 2011 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:21232997
Ichimiya H et al. Compressive mechanical stress promotes osteoclast formation through RANKL expression on synovial cells. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17321443
Sandra F et al. Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas. 2006 Oral Oncol. pmid:16413220
Martin CK et al. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. 2012 Oral Oncol. pmid:22265717
Han X et al. Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. 2009 Oral Microbiol. Immunol. pmid:19416447
Yildirim S et al. Human cytomegalovirus, Epstein-Barr virus and bone resorption-inducing cytokines in periapical lesions of deciduous teeth. 2006 Oral Microbiol. Immunol. pmid:16476020
Garlet GP et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. 2006 Oral Microbiol. Immunol. pmid:16390336
Suda T et al. Regulatory roles of beta-catenin and AP-1 on osteoprotegerin production in interleukin-1alpha-stimulated periodontal ligament cells. 2009 Oral Microbiol. Immunol. pmid:19702951
Fukada SY et al. Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases. 2009 Oral Microbiol. Immunol. pmid:19121066
Nakamura H et al. Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo. 2008 Oral Microbiol. Immunol. pmid:18402604
Lu HK et al. An acute injection of Porphyromonas gingivalis lipopolysaccharide modulates the OPG/RANKL system and interleukin-6 in an ovariectomized mouse model. 2008 Oral Microbiol. Immunol. pmid:18402608
Kawai T et al. Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model. 2007 Oral Microbiol. Immunol. pmid:17488448
Katagiri T and Takahashi N Regulatory mechanisms of osteoblast and osteoclast differentiation. 2002 Oral Dis pmid:12108759
Yamamoto T et al. Mechanical stress induces expression of cytokines in human periodontal ligament cells. 2006 Oral Dis pmid:16476039
Yamamoto K et al. Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. 2011 Oral Dis pmid:21771211
Park OJ et al. The association of osteoprotegerin gene polymorphisms with periodontitis. 2008 Oral Dis pmid:18938269
Nakano M et al. Inhibitory effect of titanium particles on osteoclast formation generated by treatment of mouse bone marrow cells with PGE2. 2003 Oral Dis pmid:12657033
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Fioramonti M et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. 2017 Oncotarget pmid:28223547
Murthy RK et al. Bone biology and the role of the RANK ligand pathway. 2009 Oncology (Williston Park, N.Y.) pmid:20128323
Shan Y et al. p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. 2010 Oncol. Rep. pmid:20204301
D'Amico L et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism. 2013 Oncol. Rep. pmid:23404437
Lv Z et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. 2014 Oncol. Rep. pmid:24337584
Martinetti A et al. Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response? 2007 Oncol. Rep. pmid:17487415
Holecki M et al. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. 2007 Obesity (Silver Spring) pmid:17712108
Son E et al. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros. 2007 Nutrition pmid:17664058
Pellegrini GG et al. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. 2016 Nutrients pmid:27409635
Martin-Bautista E et al. Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. 2010 Nutr Res pmid:20579524
Marini H et al. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. 2010 Nutr Metab Cardiovasc Dis pmid:19631515
Huang JW et al. Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. 2014 Nutr Metab Cardiovasc Dis pmid:24361071
Mori T et al. RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. 2004 Nucleic Acids Res. pmid:15562003
Azuma Y [Animal models of osteoporosis and development of anti-osteoporotic agents]. 2007 Nippon Yakurigaku Zasshi pmid:17878615
Wada T [RANKL inhibition in bone metastases]. 2013 Nippon Yakurigaku Zasshi pmid:23302944
Kawaguchi H [Approach for therapeutic targets of osteoarthritis]. 2011 Nippon Yakurigaku Zasshi pmid:21747205
Abe M [Hypercalcemia in myeloma]. 2007 Nippon Rinsho pmid:18069268
Inoue D and Matsumoto T [Recent advances in basic research of bone metabolism]. 2002 Nippon Rinsho pmid:11979916
Suzuki Y et al. [Bone destruction and bone loss in rheumatoid arthritis--mechanism, prevention and treatment]. 2002 Nippon Rinsho pmid:11979937
Suda T and Miyaura C [Recent advance in basic research for osteoporosis]. 2004 Nippon Rinsho pmid:15035090
Inoue D [Recent advances in research of bone resorption]. 2002 Nippon Rinsho pmid:11979946
Udagawa N and Takahashi N [Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function]. 2002 Nippon Rinsho pmid:11979968
Tsuda E [Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases)]. 2002 Nippon Rinsho pmid:11979969
Koshihara Y [Recent progress of bone cell culture system (review)]. 2002 Nippon Rinsho pmid:11979973
Miyaura C [LPS]. 2004 Nippon Rinsho pmid:15035108
Tanaka Y [Adhesion molecules in the context with bone remodeling and osteoporosis]. 2004 Nippon Rinsho pmid:15035110
Tomoyasu A and Higashio K [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)]. 2004 Nippon Rinsho pmid:15035190
Sohen S [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases]. 2004 Nippon Rinsho pmid:15035207
Tanaka Y [Secondary osteoporosis due to systemic autoimmune diseases and rheumatic diseases]. 2004 Nippon Rinsho pmid:15035208
Fukunaga J and Sugahara T [Osteoporosis induced by immunosuppressant]. 2004 Nippon Rinsho pmid:15035219
Juji T and Tanaka S [Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]. 2004 Nippon Rinsho pmid:15035230
Sato K [Graves' disease and bone metabolism]. 2006 Nippon Rinsho pmid:17154099
Tsuda E and Higashio K [Osteoclastogenesis inhibitory factor (OCIF)/OPG]. 1998 Nippon Rinsho pmid:9648461
Sato K [Osteoclast-activating factors (OAF)]. 2004 Nippon Rinsho pmid:15658306
Chaki O [Osteoporosis]. 2006 Nippon Rinsho pmid:16689336
Takahashi N et al. [Osteoprotegerin (OPG)]. 2010 Nippon Rinsho pmid:20960766
Yasuda H [OPG, anti-rANKL antibody]. 2005 Nippon Rinsho pmid:16164225
Takahashi N et al. [Osteoprotegerin (OPG)]. 2005 Nippon Rinsho pmid:16149650
Nakamura M et al. [Osteoclastogenesis and bone resorption]. 2009 Nippon Rinsho pmid:19432105

Table of Content